W.A.L. Tonino

W.A.L. (Pim) Tonino is a Full Professor in the Faculty of Biomedical Engineering at Eindhoven University of Technology, specializing in Cardiovascular Biomechanics. With over 14,532 citations according to Scopus, his research has made significant contributions to the field of cardiovascular interventions and diagnostics.

Dr. Tonino's research interests focus on Cardiovascular Biomechanics, particularly in the areas of Fractional Flow Reserve, Percutaneous Coronary Intervention, Coronary Artery Disease, and Angiography. His work bridges engineering principles with clinical cardiology to improve diagnostic accuracy and treatment outcomes for cardiovascular patients. He has developed expertise in virtual patient modeling, hemodynamic assessment, and medical device validation for cardiac applications.

Analysis of his recent publications (2024-2025) reveals a strong trend toward computational modeling of coronary physiology and innovative diagnostic techniques for cardiovascular disease. His work spans from fundamental biomechanical research to clinical trials, with particular emphasis on virtual patient cohorts, wearable cardiac monitoring, and microvascular assessment techniques. The research demonstrates increasing integration of engineering approaches with clinical cardiology to solve complex diagnostic and therapeutic challenges.

Dr. Tonino teaches the course Pathophysiology of the cardiovascular system and has supervised 4 research projects. His academic network includes collaborations across multiple institutions focused on cardiovascular research, as evidenced by his co-authorship on numerous clinical trials and computational studies. He has contributed to datasets including ValveValid and synthetic aortic valve stenosis geometries for in silico trials.

His laboratory work focuses on cardiovascular biomechanics with emphasis on coronary physiology assessment, virtual patient modeling, and development of novel diagnostic approaches for coronary artery disease. The research group maintains strong connections with clinical cardiology departments and participates in multicenter clinical trials evaluating new diagnostic and therapeutic approaches for cardiovascular disease.